| Autor: |
Higashi Y; Division of Cancer Medicine, Dept. of Gastroenterological Surgery, Kanazawa University., Nakamura K, Hirose A, Sakai S, Kinoshita J, Makino I, Hayashi H, Oyama K, Inokuchi M, Miyashita T, Tajima H, Takamura H, Ninomiya I, Fushida S, Ohta T |
| Jazyk: |
japonština |
| Zdroj: |
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2017 Nov; Vol. 44 (12), pp. 1326-1328. |
| Abstrakt: |
A 69-year-old man with multiple liver metastases from sigmoid colon cancer received mFOLFOX6 plus cetuximab(Cmab) chemotherapy. A partial response was observed; hence, we performed an extended left hepatectomy, 3 partial liver resections, and a sigmoidectomy. After 4 courses of CapeOX, a recurrent lesion occurred between S8 and S7 of the liver, and we changed the regimen to FOLFIRI plus bevacizumab(BV). Three months later, he had Grade 3 febrile neutropenia and CT scan findings showed ground glass opacity in the superior lobes of both lungs. We diagnosed pneumocystis pneumonia(PCP)and administered steroids and trimethoprim/sulfamethoxazole. The signs of PCP thus improved. PCP during chemotherapy for gastrointestinal cancer is rarely reported, but recently it has increased. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
